REVA Receives Approval for Clinical Trial
May 23, 2011 23:00 ET
|
REVA Medical Inc
SAN DIEGO and SYDNEY, Australia, May 23, 2011 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") is pleased to announce it has received regulatory approval from the German...
Access to 2011 Annual Meeting
May 16, 2011 22:52 ET
|
REVA Medical Inc
SAN DIEGO and SYDNEY, Australia, May 16, 2011 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") will hold its 2011 Annual General Meeting of Stockholders on 23 May 2011, at...
REVA Expands Management Team With Key Executive Hire
February 25, 2011 10:00 ET
|
REVA Medical Inc
SYDNEY, Australia and SAN DIEGO, Feb. 25, 2011 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company"), which is developing a novel bioresorbable slide and lock drug-eluting...
REVA Closes A$85 Million IPO
December 21, 2010 08:00 ET
|
REVA Medical Inc
SAN DIEGO and SYDNEY, Australia, Dec. 21, 2010 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") is pleased to announce that its Initial Public Offering (the Offer) has...